MyndTec Receives FDA 510(k) Clearance for MyndMove 2.0, its Second Generation Neuromodulation Device, for Clinical and Home Use

Mississauga, Ontario, March 8, 2022 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an...

Ownership of Milos and Kathrin Popovic in MyndTec Inc.

Toronto, Canada – February 24, 2022 – MyndTec Inc. (MyndTec or Company) filed and received...

Ownership of James Anderson in MyndTec Inc.

Toronto, Canada – February 24, 2022 – MyndTec Inc. (MyndTec or the Company) filed and...

MYNDTEC INC. ANNOUNCES CLOSING OF DISTRIBUTION OF SECURITIES ISSUABLE UPON CONVERSION OF SUBSCRIPTION RECEIPTS AND LISTING ON CSE

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. MISSISSAUGA,...

Ownership of Peter Harvey Griggs in MyndTec Inc.

Toronto, Canada – February 24, 2022 – MyndTec Inc. (MyndTec or the Company) filed and...

MyndTec Inc. Files Final Prospectus and Receives Conditional Listing Approval from the Canadian Securities Exchange

Mississauga, Ontario (Newsfile Corp. – February 16, 2022) – MyndTec Inc. (“MyndTec” or the “Company”)...